THE ACUTE CORONARY SYNDROME: POSSIBILITY UP-TO-DATE THERAPY (literature review. Part III)
https://doi.org/10.51523/2708-6011.2010-7-4-3
Abstract
The information about the modern medical treatment of the acute coronary syndrome was presented in the this review.
References
1. Беленков, Ю. Н. Функциональная диагностика сердечно-сосудистых заболеваний / Ю. Н. Беленков, С. К. Терновой. - М.: «Геотар-Медиа», 2007. - 976 с.
2. Берштейн, Л. Л. Оценка эффективности реперфузии при остром инфаркте миокарда: современные концепции и методы / Л. Л. Берштейн, В. И. Новиков, Ю. Н. Гришкин // Рос. кардиол. журн. - 2005. - № 1 (51). - С. 73-79.
3. Влияние отсроченной коронарной ангиопластики после тромболитической терапии на исход острого инфаркта миокарда / С. А. Заволожин [и др.] // Кардиология. - 2006. - Т. 46, № 10. - С. 8-13.
4. Инфаркт миокарда; диагностика и лечение: пособие для врачей / Л. З. Полонецкий [и др.]; под ред. Л. З. Полонецкого. - Минск: Доктор Дизайн, 2005. - 112 с.
5. Пархоменко, А. Н. Жизнеспособный миокард и кардиопротекция: возможности метаболической терапии при острой и хронической формах ишемической болезни сердца / А. Н. Пархоменко // Украинский медицинский журнал. - 2001. - № 3 (23). - С. 5-11.
6. Шпектор, А. В. Реперфузионная терапия острого инфаркта миокарда / А. В. Шпектор, Е. Ю. Васильева // Бюл. НЦССХ им. А. Н. Бакулева РАМН. - 2004. - С. 38-46.
7. A comparison of pharmacologic therapy with/without timely coronary intervention vs. primary percutaneous intervention early after ST-elevation myocardial infarction: the WEST (Which Early ST-Elevation myocardial infarction Therapy) study / P. W. Armstrong and WEST steering Committee // Eur. Heart J. - 2006.
8. A score predict failure of reperfusion after fibrinolytic therapy for acute myocardial infarction / J. K. French [et al.] // Lancet. - 2003. - Vol. 145(3). - P. 508-514.
9. Aborted myocardial infarction in patients with ST-elevation: insight from the ASSENT-3 ECG substudy / T. Taher [et al.] // J. Am. Coll. Cardiol. - 2004. - Vol. 44. - P. 38-43.
10. Activated partial thromboplastin time and outcome after thrombolytiс therapy for acute myocardial infarction: result from the GUSTO-I trial / C. B. Granger [et al.] // Circulation. - 1996. - Vol. 93. - P. 870-878.
11. Bhatia, L. Clinical implication of ST-segment non-resolution after thrombolysis for myocardial infarction / L. Bhatia, G. J. Clesham, D. R. Turner // J. R. Sjc. Med. - 2004. - Vol. 97(12). - P. 566-570.
12. Coronary angiographic finding after non-Q wave myocardial infarction: an analysis from the VANOWISH trial (abstr.) / W. E. Boden [et al.] // Eur. Heart J. - 1997. - Vol. 18. - 123 p.
13. Coronary intervention for persistent occlusion after myocardial infarction / J. S. Hochman [et al.] // N. Engl. J. Med. - 2006. - Vol. 355. - P. 2395-2407.
14. Danish multicenter randomized study of invasive versus conservative treatment in patients with inducible ischemia after thrombolysis in acute myocardial infarction (DANAMI) DANish trial in ACUTE Myocardial Infarction / J. K. Madsen [et al.] // Circulation. - 1997. - Vol. 96. - P. 748-755.
15. Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications / T. F. Luscher [et al.] // Circulation. - 2007. - Vol. 115. - P. 1051-1058.
16. Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour / E. Boersma [et al.] // Lancet. - 1996. - Vol. 348. - P. 771-775.
17. Five-year outcome of an interventional strategy in non-ST-elevation acute coronary syndrome - the British Heart Foundation RITA 3 randomized trial / K. A. Fox [et al.] // Lancet. - 2005. - Vol. 366. - P. 914-920.
18. Grines, C. L. Should thrombolysis or primary angioplasty be the treatment of choice for acute myocardial infarction? Primary angioplasty - the strategy of choice / C. L. Grines // N. Engl. J. Med. - 1996. - Vol. 335. - P. 1313-1316.
19. Grunewald, M. Meta-analysis of all available published clinical trials (1958-1990) on thrombolytic therapy for AMI: Relative efficacy of different therapeutic strategies / M. Grunewald, E. Seifreid // Fibrinolysis. - 1994. - Vol. 8. - P. 67-86.
20. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and morbidity results from all randomized trials of more than 1000 patients. Fibrinolytic Therapy Trialists´ (FIT) Collaborative Group // Lancet. - 1994. - Vol. 343. - P. 311-322.
21. Insulin resistance as a predictors for restenosis after coronary stenting / K. Nishioa [et al.] // International Journal of Cardiology. - 2005. - Vol. 103. - P. 128-134.
22. ACC/AHA 2007 Guidelines for the Management of Patients with Unstable Angina / Non ST-Elevation Myocardial Infarction: Executive Summary / L. Jeffrey [et al.] // Circulation. - 2007. - Vol. 116. - P. 803-877.
23. Keely, E. C. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomized trials / E. C. Keely, J. A. Boura, C. L. Grines // Lancet. - 2003. - Vol. 361. - P. 120-130.
24. Late thrombosis of drug-eluting stents: a meta-analysis of randomized clinical trials / A. A. Bavry [et al.] // Am. J. Med. - 2006. - Vol. 119. - P. 1056-1061.
25. Long distance transport for primary angioplasty vs. immediate thrombolysis in acute myocardial infarction. Final results of the randomized national multicentre trial - PRAGUE-2 / P. Widimsky [et al.] // Eur. Heart J. - 2003. - Vol. 24. - P. 94-104.
26. Mortality and prehospital thrombolysis for acute myocardial infarction: a meta-analysis / L. J. Morrison [et al.] // J.A.M.A. - 2000. - Vol. 283. - P. 2686-2692.
27. The Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 investigators. Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomized trial in acute myocardial infarction / Lancet. - 2001. - Vol. 358. - P. 605-613.
28. The GISSI Investigators Ten-year follow-up of the first megatrial testing thrombolytic therapy in patients with acute myocardial infarction: result of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarcto-1 study / M. G. Franzosi [et al.] // Circulation. - 1998. - Vol. 98. - P. 2659-2665.
29. The ISIS-2 Collaborative Group ISIS-2: 10 years survival among patients with suspected acute myocardial infarction in randomized comparison of intravenous streptokinase, oral aspirin, both, or neither / C. Baigent [et al.] // B.M.J. - 1998. - Vol. 316. - P. 1337-1343.
30. Verheugt, F.W.A. Aborted myocardial infarction: a new target for reperfusion therapy / F.W.A. Verheugt, B. J. Gersh, P. W. Armstrong // Eur. Heart J. - 2006. - Vol. 27. - P. 901-904.
Review
For citations:
Salivonchik D.P. THE ACUTE CORONARY SYNDROME: POSSIBILITY UP-TO-DATE THERAPY (literature review. Part III). Health and Ecology Issues. 2010;(4):19-25. (In Russ.) https://doi.org/10.51523/2708-6011.2010-7-4-3
Views: 264
Email this article 